MANILA, Philippines — Another private hospital was given a compassionate special permit (CSP) to use Ivermectin as treatment for COVID-19 patients, the Food and Drug Administration (FDA) said yesterday.
Tag: SARS-CoV-2
This disease is very manageable & easy to treat. They censor us because we tell the truth – they don’t want us to treat people. They want to sell vaccines.
In an interview with Alan Jones, Craig Kelly MP discusses the vaccine rollout mishaps and yet again, rightfully points out the myriad of medical specialists around the world who support the use of ivermectin for the prophylaxis and treatment of their Covid-19 patients with the backup of extensive positive data.
Source: The New American Author: Annalisa Pesek Calls are increasing for investigations into Dr. Anthony Fauci’s intentional suppression of inexpensive and easily accessible, life-saving treatments for COVID-19. “If you put [hydroxychloroquine] back out there [as a therapeutic that could work], it’s quite evident that Dr. Fauci, Dr. Woodcock, Rick Bright, are responsible for hundreds of thousands of […]
Categories
Algeria Australia Bahrain Belgium China Chloroquine Clinical Trials Costa Rica Egypt El Salvador Finland Greece Hydroxychloroquine India Indonesia Italy Lebanon Malaysia Medical Study Morocco Motion Video Clip Observational Study Opinion Panama RESEARCH South Korea Spain Switzerland Thailand Turkey UAE Uganda US Venezuela
The Chloroquine Wars Part XV – How to Rig Research: Surgisphere Part II
It would be a historically amazing feat of maneuvering bureaucracy, worthy of its own epic book, movie, or perhaps a campfire song, to have wrangled that much data out of those hospitals with highly variable regulations and procedures, nearly all of which are in the U.S. healthcare system.
Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.
The severe weaknesses of this study make it uninformative about whether ivermectin is beneficial in early COVID-19 treatment. Yet, the authors misleadingly conclude that their findings “do not support the use of ivermectin for treatment of mild COVID-19”, as if they had enough quality data to make that case, which they do not.
FLCCC Weekly Update: “Big Science vs Little Science”—April 14, 2021 Drs. Jose Morgenstern and Jose Redondo of the Dominican Republic share their new ivermectin study and tell the story of how they discovered the efficacy of ivermectin in April, 2020.
It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.
Hydroxychloroquine also can act as an oral hypoglycemic agent, as patients with diabetes taking hydroxychloroquine for rheumatologic diseases had a significant reduction in hemoglobin A1c when compared to methotrexate,40 and thus can serve to reduce hyperglycemia, a possible COVID‐19 risk factor for disease severity.
Dr. Steven Hatfill, infectious disease expert, says the medical bureaucracy blocked an effective treatment in hydroxychloroquine so they could push through experimental vaccines.
Ivermectin, a medicine for parasites, has been around for four decades. While not authorized for use against COVID-19, dozens of studies show materially positive results. At well-established human dosage levels, the drug is safe: hundreds of millions of people are treated with it every year mostly in the tropics for various parasite-borne diseases, such as River Blindness in Nigeria.
Immediately following HCQ’s Trump moment, the media went on an all-out blitz to associate the topic of HCQ with a sense of fear. Fear of Trump, fear of death, fear of incompetence, fear of opposing scientific authorities, fear of using medicine needed by somebody else, and fear of the unknown. And the campaign of fear didn’t stop there.
The primary effect of the article was likely to further ingrain a partisan association with the subject matter, along with the subtext, “Whatever good SCIENCE exists, it can only be on our side [so you won’t need to think any more about it].”
The authors emphasize the historically significant & relevant role of empiric treatment in an attempt to reduce death. Doing nothing is not good medicine.
The case involving John W. Swanson, a farmer from Stafford in Genesee County, is the latest of several in which judges have ordered local hospitals to give Ivermectin to patients suffering from the virus.
An Internist, cardiologist and professor of medicine, Dr McCollough treats covid patients and was involved in two major studies indicating that treatment is the key to getting covid under control.
“Waiting for another Randomized Controlled Trial is asinine,” Dr. Ram Yogendra says. “Do the trial. Do the study. But treat the patient.” IVERMECTIN
The World Health Organization and National Institutes of Health now have all the data they need to recommend ivermectin to prevent and treat COVID-19. And those who want to end this pandemic now, for all countries rich and poor, should welcome that move.
One of the most disturbing aspects of the COVID-19 pandemic is the strange singularity of the ultimate solution, or at least the one preferred by the world’s most powerful people and their media: vaccines.
The civil rights organisation AfriForum & Dr George Coetzee today achieved a further success in the fight for access to ivermectin including off-label use.
Our investigation of a large national cohort appears to support early administration (within the first 3 to 7 days of COVID-19 diagnosis) of HCQ in mild COVID-19 disease in an outpatient setting for reducing hospitalizations and deaths without any serious adverse HCQ-related effects.
If this finding is confirmed in future clinical trials, HCQ as a cheap and available drug may still play a role in a specific population with respect to reducing COVID-19 burden, particularly in resource-poor countries.
We discussed the Surgisphere debacle and other stories of “engineered research” during the pandemic, most of which I am currently preparing articles about.
Suppose that we want to rig a medical study despite the participation of mostly or entirely caring doctors and researchers with unimpeachable character and credentials.
While HCQ looks very safe overall for COVID-19 patients, it looks safest when used as a prophylactic or therapeutic for early stage COVID-19 patients, once again affirming the Primary HCQ Hypothesis as the strongest version of the HCQ Hypothesis.
“I am deeply troubled that the WHO made this hasty decision on guidance before reviewing all available data,” said Pierre Kory, MD, MPH, president and chief medical officer of the FLCCC.
“Their recommendation ignores the evidence, creates more controversy, and will only lead to continuing suffering and death from COVID-19. There are now over 24 randomized trials results
that have been reported to the Unitaid/WHO team yet todays guidance was inexcusably based on a faulty analysis of just 16 of the available trials. Further, these erroneous findings directly conflict
with numerous other peer-reviewed expert analyses that have found the data overwhelmingly demonstrates that ivermectin saves lives from COVID-19. There is no reason not to recommend it
for everyone as a safe drug for prevention and treatment.”
Source: FLCCC Alliance Dr. Lionel Lee and his family came down with COVID-19 in the fall of 2020. Dr. Lee himself experienced the worst symptoms— and had debilitating shortness of breath. Then Dr. Lee remembered reading about ivermectin from materials he received in an email from FLCCC Alliance co-founder Dr. Paul Marik. He decided to […]
The purpose of this study was to assess the effect of oral Ivermectin treatment, which has been associated with iota-carrageenan in repeated doses through the nasal and oral topical route, on the appearance and eventual progression of COVID-19 disease in a healthy population that are exposed to it and have a higher risk of contagion of SARS-COV-2 for being health personnel from
Ivermectin had a significant effect (p=0.003) in achieving medical release. The treatment with ivermectin could significantly prevent the evolution to serious stages since the experimental group did not present any patient with referral to critical hospitalization.
Did the Netherlands work out that early outpatient treatment using hydroxychloroquine, ivermectin & other drugs, hospitalisations can reduce by 80% or more?
It would take just a few weeks to bring down new hospitalizations for COVID-19 to around 40 per day in the country, if general practitioners were authorized to treat the disease early, using a range of early treatment medications, including those now exposing doctors to penalties of up to 150,000 euros!
Source: Rounding the Earth Author: Mathew Crawford The story of why hydroxychloroquine (HCQ) has not been used broadly in most Western nations (primarily in the sphere of influence of those countries with the largest pharmaceutical industries) to treat COVID-19 patients during the first days of the disease progression is a bizarre tale. It involves the strange […]
To say that hydroxychloroquine and ivermectin kill is a fallacy. Who wants to do the early treatment, do it. Whoever doesn’t want it, don’t do it
From an ingenious intuition of the founder, Mauro Rango, an Italian living in the Mauritius Islands. There, the Coronavirus was quickly eradicated in the beginning, with drugs that we have known for decades, such as Azithromycin, Hydroxychloroquine or Cortisone, while in Italy people died like flies. How was it possible that in Africa, where health care is not as advanced as in Italy, such marvellous results were achieved, while in Italy the spread of the disease could not be contained?
As part of Mission Sagar – IV, Indian Naval Ship Jalashwa arrived at Port Ehoala, Madagascar on 22 March 2021. The ship will deliver a consignment of 1,000 Metric Tonne of rice and 100,000 Hydroxychloroquine tablets in response to an appeal made by Madagascar for assistance to deal with natural calamities.
The big problem is that people do not recognize that the treatment works. Lives are thus endangered. They listen to people who are not caring for patients.
Santin’s endorsement is not only important but broad. He said he has seen ivermectin work at every stage of COVID — preventing it, eliminating early infection, quelling the destructive cytokine storm in late infection, and helping about a dozen patients so far who suffered months after COVID.
Why is Ivermectin not approved?
Because it does not leave revenue to anyone, it does not generate returns, you cannot make partisan discretion with it, and no one can win an election by applying it, or buy a yacht with its dividends.
The group that didn’t take the ivermectin, over 3 months it was fifty-eight percent. Fifty-eight percent of those doctors, nurses and orderlies contracted coronavirus.
In the 788 group, the same doctors, nurses and orderlies across the 4 hospitals, the number of infections that they had, was zero. ZERO, that were treated with ivermectin.
Portuguese doctors reacted: since the prescription of hydroxychloroquine was forbidden to them, they fell back on ivermectin and administered it more and more massively.
Antiviral therapy is only of interest during the early and intermediate viral phase when the virus is present and replicates, and is of no use during the late inflammatory phase (cytokine storm). Most therapeutic trials, unfortunately, have been carried out in hospitalized patients, which is to say probably often too late, because the patients are in the early inflammatory phase.